StockData
Kiora Pharmaceuticals Inc logo

Kiora Pharmaceuticals Inc (KPRX) stock

KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.82−0.11 (-11.31%)

Close on Nov 18, 2026Market cap $3.65MP/E –Yield –

Kiora Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Kiora Pharmaceuticals's pe ratio was 2.7× on Apr 30, 2025.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 20252.7×+0.9
2024Dec 31, 20241.8×–

More Kiora Pharmaceuticals figures

See a number that looks wrong?